Latest Security News

Bailador Technology Investments reported $28 million in FY26 cash realisations and 32% weighted revenue growth across its portfolio, while profit after tax fell to $6.9 million. The technology investment fund also reaffirmed its fully franked dividend strategy despite a 7.5% gross portfolio return that fell short of internal targets.

Matrix Critical Minerals has opened an IPO seeking up to $12 million to advance Orbit Resources’ Narraburra Rare Earths Project. Eligible Orbit shareholders can apply for up to 10 million Matrix shares, although the proposed listing still depends on funding, ASX approval and shareholder consent.

Volt Resources has secured a $1.5 million placement to fund its Alabama high-purity graphite refinery study, advance pilot work and reduce debt. Almost half the raise is subscribed by two directors, although their participation still requires shareholder approval.

COSOL’s revenue fell 15.6% in FY26 and the ASX-listed asset management technology company swung to a $4.0 million statutory loss after goodwill impairments. Management is betting that leaner operations, new transport contracts and AI-led services can restore profitable growth, but the recovery still needs to show up in revenue.

PARKD has secured an exclusive three-year partnership with ASX-listed Symal across Victoria and South Australia, alongside an A$800,000 placement priced at a premium. The deal expands PARKD’s east coast delivery network, although future projects and revenue remain uncommitted.

Delorean Corporation has secured a non-binding $20 million financing mandate from Westpac for its NSW1 Horsley Park bioenergy project, taking identified funding to about 81% of the estimated build cost. The project still needs binding finance documents and a further $11.6 million before financial close can be reached.

Great Southern Mining has reported a run of high-grade gold intercepts at Golden Boulder, extending mineralisation across the northern 1.1 kilometres of a 3.5-kilometre trend. The exploration gains arrive alongside A$2.524 million in cash and a reported 1.13 quarters of funding at the quarter-end spending rate.

Stavely Minerals is testing smaller and potentially easier-to-fund development routes for Thursday’s Gossan after a large open-pit study delivered strong economics but demanded substantial upfront capital. The alternatives could reduce capital intensity, although the company expects they may produce lower NPVs.

Prescient Therapeutics has reached the first planned review threshold in its PTX-100 Phase 2a lymphoma study, while a completed A$6.0 million raise extends funding beyond the December milestone. The review will assess safety and efficacy, but is not a study completion or a new clinical result.

The US FDA has supported six of seven elements NeuroScientific Biopharmaceuticals put forward for its planned StemSmart Phase 2 Crohn’s disease trial. The remaining issue is a manufacturing control for viral contamination, while trial commencement remains targeted for the end of 2026 and subject to further requirements.

Kinetiko Energy is preparing to submit a permit that could allow limited gas sales from its Brakfontein project in early 2027, while engineering, procurement and drilling plans advance in parallel. The company has also shortlisted three candidates for its next chief executive.

Elixinol Wellness has lifted combined hemp sales 12% to $6.41 million in the first nine months of 2026, while unaudited gross profit rose 41%. Two major grocery programs are now fully supplied through 2027, with Hemp Gold Protein due back at Costco in Australia and New Zealand.